Deutsche Bank Securities - New York, NY Jun 2012 - Aug 2012
Investment Banking Summer Analyst
Smith College Investment Club - Northampton, MA Sep 2010 - May 2012
Sector Head (Consumer & Retail)
PwC Consulting - Shanghai May 2011 - Aug 2011
Summer Intern
John Leggott Student Orchestra - United Kingdom Sep 2008 - May 2009
Second Violinist
Education:
Smith College 2010 - 2013
BA, Mathematics, Economics
University of Pittsburgh Jan 2010 - Aug 2012
Data Warehouse Analyst
University of Pittsburgh Jan 2010 - Aug 2012
Obiee Architect
University of Pittsburgh Aug 2001 - Dec 2009
Developer
Mellon Bank Sep 1999 - Jul 2001
Developer
Education:
Robert Morris University 1997 - 1999
Master of Science, Masters, Master of International Studies
Peking University 1987 - 1991
Bachelors, Bachelor of Science, Business
Skills:
Databases Data Warehousing Pl/Sql Unix Obiee Etl Data Modeling Data Analysis Systems Analysis Visio Access Oracle Pentaho Oracle Sql Perl Database Design Data Management Javascript Html
Charanjit R. Behl - Hauppauge NY Jorge C. deMeireles - Syosset NY Vincent D. Romeo - Massapequa Park NY Anthony P. Sileno - Brookhaven Hamlet NY Harish K. Pimplaskar - Lindenhurst NY Wei J. Xia - Melville NY
Assignee:
Nastech Pharmaceutical Company, Inc. - Hauppauge NY
International Classification:
A61K 3140
US Classification:
514408
Abstract:
A method is disclosed for increasing the solubility of clemastine through the use of organic acid or its salts as a solubilizing agent. Particularly useful as solubilizing agents are salts of carboxylic acids, such as fumarate, maleate and citrate. Pharmaceutical compositions containing clemastine, and organic acids or its salts as solubilizing agents, are also disclosed.
Intranasal Formulations For Promoting Sleep And Method Of Using The Same
Charanjit R. Behl - Hauppauge NY Jorge C. DeMeireles - Syosset NY Harish K. Pimplaskar - Lindenhurst NY Vincent D. Romeo - Massapequa Park NY Anthony P. Sileno - Brookhaven Hamlet NY Wei J. Xia - Melville NY
Assignee:
Nastech Pharmaceutical Company, Inc. - Hauppauge NY
International Classification:
A61K 908 A61K 31435
US Classification:
514357
Abstract:
Intranasal dosage units for promoting sleep in a mammal are disclosed. The dosage units are in the form of an aqueous buffered solution having a pH greater than 7. 0, a sleep-promoting amount of Doxylamine, and an effective amount of an anionic surfactant. The anionic surfactant amount is an amount effective to provide a peak plasma concentration of Doxylamine to be reached within 30 minutes of administering the dosage unit to the nasal mucosa of a mammal. The dosage units are particularly suitable for administration to humans.